Cutia Therapeutics (HKSE:02487) Days Inventory : 288.47 (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cutia Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Cutia Therapeutics's Average Total Inventories for the six months ended in Jun. 2023 was HK$22.6 Mil. Cutia Therapeutics's Cost of Goods Sold for the six months ended in Jun. 2023 was HK$14.3 Mil. Hence, Cutia Therapeutics's Days Inventory for the six months ended in Jun. 2023 was 288.47.

The historical rank and industry rank for Cutia Therapeutics's Days Inventory or its related term are showing as below:

HKSE:02487' s Days Inventory Range Over the Past 10 Years
Min: 158.3 Med: 1354.15 Max: 1538.71
Current: 158.3

During the past 3 years, Cutia Therapeutics's highest Days Inventory was 1538.71. The lowest was 158.30. And the median was 1354.15.

HKSE:02487's Days Inventory is ranked better than
57.95% of 654 companies
in the Biotechnology industry
Industry Median: 192.63 vs HKSE:02487: 158.30

Cutia Therapeutics's Days Inventory declined from Jun. 2022 (1,679.76) to Jun. 2023 (288.47).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cutia Therapeutics's Inventory Turnover for the six months ended in Jun. 2023 was 0.63.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cutia Therapeutics's Inventory-to-Revenue for the six months ended in Jun. 2023 was 0.60.

Cutia Therapeutics Days Inventory Historical Data

The historical data trend for Cutia Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cutia Therapeutics Days Inventory Chart

Cutia Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Days Inventory

1,538.71

1,169.59

180.07

Cutia Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory	-	1,679.76	1,132.32	288.47	112.94

Competitive Comparison of Cutia Therapeutics's Days Inventory

For the Biotechnology subindustry, Cutia Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cutia Therapeutics's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cutia Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Cutia Therapeutics's Days Inventory falls into.

Cutia Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cutia Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

	Days Inventory (A: Dec. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2021 )	+	Total Inventories (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (2.209	+	22.33)	/	2 )	/	3.829	*	365
=	12.2695					/	3.829	*	365
=	1,169.59

Cutia Therapeutics's Days Inventory for the quarter that ended in Jun. 2023 is calculated as:

	Days Inventory (Q: Jun. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2022 )	+	Total Inventories (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (22.33	+	22.908)	/	2 )	/	14.31	*	365 / 2
=	22.619					/	14.31	*	365 / 2
=	288.47

Cutia Therapeutics (HKSE:02487) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cutia Therapeutics's Inventory Turnover for the six months ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	14.31	/	22.619
	=	0.63

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cutia Therapeutics's Inventory to Revenue for the six months ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	22.619	/	37.564
	=	0.60

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Cutia Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of Cutia Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Cutia Therapeutics (HKSE:02487) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cutia Therapeutics (HKSE:02487) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

436 Heng Feng Road, 20th Floor, Huanzhi Building, Jingan District, Shanghai, CHN, 200070

Website

https://www.cutiatx.com

Cutia Therapeutics is a dermatology-focused biopharmaceutical company focused on the broader dermatology treatment and care therapeutic areas, including localized adipose accumulation management medication, scalp diseases and care, skin diseases and care, and topical anesthesia. Its core product is CU-20401, which is a recombinant mutant collagenase that targets obesity, overweight, or other localized adipose accumulation-associated metabolic diseases.

Executives

Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Fil Limited	2201 Interest of corporation controlled by you
Shen Nan Peng	2201 Interest of corporation controlled by you
Snp China Enterprises Limited	2201 Interest of corporation controlled by you
Hongshan Capital Growth Fund V, L.p.	2201 Interest of corporation controlled by you
Hsg Growth V Holdco Q, Ltd	2201 Interest of corporation controlled by you
Hsg Growth V Management, L.p.	2201 Interest of corporation controlled by you
Hsg Holding Limited	2201 Interest of corporation controlled by you
Ma Yun	2201 Interest of corporation controlled by you
Su Zhou Tong Yu Tou Zi Guan Li He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Su Zhou Yun Zhang Tou Zi Zi Xun You Xian Gong Si	2201 Interest of corporation controlled by you
Su Zhou Tong He Er Qi Chuang Ye Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Su Zhou Fu Yan Chuang Ye Tou Zi Guan Li He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Aurora Cutis Limited	2301 Trustee

Cutia Therapeutics (HKSE:02487) Headlines

No Headlines